Abstract
Between 1985 and 1996, 18 patients with diffuse centrocytic lymphoma (DCL), including nine patients with an established histological and phenotypic diagnosis of mantle cell lymphoma (MCL), received 19 courses of high-dose chemotherapy (HDCT) followed by hematopoietic stem cell transplantation. Five patients received HDCT as consolidation treatment after first-line standard chemotherapy, and 14 after a relapse or progression, including one patient in early relapse after the first transplant. Six patients (33%) were in complete response (CR) prior to HDCT and 12 (67%) were in partial response: 10 (83%) of these 12 patients achieved CR at day 60 following HDCT. With a median follow-up of 30 months after HDCT, the 2-year overall and progression-free survivals of the whole series are 91 and 75%, respectively. The 2-year progression-free survivals are 74 and 75%, respectively, in the MCL and DCL subgroups.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blay, JY., Sebban, C., Surbiguet, C. et al. High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin’s lymphomas: a single center experience on 18 patients. Bone Marrow Transplant 21, 51–54 (1998). https://doi.org/10.1038/sj.bmt.1701046
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701046
Keywords
This article is cited by
-
Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma
Cancer Chemotherapy and Pharmacology (2008)
-
Stem cell transplantation for mantle cell lymphoma: if, when and how?
Bone Marrow Transplantation (2005)
-
Rituximab: enhancing stem cell transplantation in mantle cell lymphoma
Bone Marrow Transplantation (2002)
-
Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?
Bone Marrow Transplantation (2001)
-
Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study
Bone Marrow Transplantation (2000)